Cargando…
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement
The expressive number of deaths and confirmed cases of SARS-CoV-2 call for an urgent demand of effective and available drugs for COVID-19 treatment. CD147, a receptor on host cells, is a novel route for SARS-CoV-2 invasion. Thus, drugs that interfere in the spike protein/CD147 interaction or CD147 e...
Autores principales: | Ulrich, Henning, Pillat, Micheli M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167302/ https://www.ncbi.nlm.nih.gov/pubmed/32307653 http://dx.doi.org/10.1007/s12015-020-09976-7 |
Ejemplares similares
-
Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19
por: Liu, Chenglong, et al.
Publicado: (2020) -
Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147)
por: Sehirli, Ahmet Ozer, et al.
Publicado: (2020) -
Kinin-B1 Receptor Stimulation Promotes Invasion and is Involved in Cell-Cell Interaction of Co-Cultured Glioblastoma and Mesenchymal Stem Cells
por: Oliveira, Mona N., et al.
Publicado: (2018) -
Can CD147 work as a therapeutic target for tumors through COVID-19 infection?
por: Ren, Hao-Lin, et al.
Publicado: (2022) -
Targeting CD147 for T to NK Lineage Reprogramming and Tumor Therapy
por: Geng, Jie-Jie, et al.
Publicado: (2017)